Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-09-23
1984-12-04
Coughlan, Jr., Paul M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544 28, 544 29, 544 30, A61K 31545, C07D50134
Patent
active
044864256
ABSTRACT:
Compounds of formula (I): ##STR1## wherein: R.sup.1 represents a lower alkyl group selected from methyl groups and ethyl groups;
REFERENCES:
patent: 4098888 (1978-07-01), Ochiai et al.
patent: 4278671 (1981-07-01), Ochiai et al.
patent: 4278793 (1981-07-01), Durckheimer et al.
patent: 4409215 (1983-10-01), Takaya et al.
"Orally Active Esters of Cephalosporin Antibiotics. II Synthesis and Biological Properties of the Acetoxymethyl Ester of Cefamandole", Walter E. Wright et al., The Journal of Antibiotics, vol. XXXII, No. 11, Nov. 1979, pp. 1155-1160.
"Orally Active Esters of Cephalosporin Antibiotics. . . . ", W. J. Wheeler et al., Journal of Medicinal Chemistry, 1979, vol. 22, No. 6, pp. 657-661.
Fujimoto Koichi
Igarashi Isamu
Ishihara Sadao
Nakao Hideo
Sugawara Shinichi
Coughlan, Jr. Paul M.
Sankyo Company Limited
LandOfFree
7-[2-(2-A minothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-met does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 7-[2-(2-A minothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-met, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 7-[2-(2-A minothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-met will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1581989